Sanofi Consumer Healthcare Showcases Portfolio of Innovative Self-Care Products at the 6th China International Import Expo

Global Health Supplements Import Accelerates Further

ShanghaiNovember 8, 2023PR Newswire -- The 6th China International Import Expo (hereinafter referred to as "CIIE") is in full swing. At the 7.2 Pavilion of the Medical Equipment and Healthcare Products Exhibition Area, Sanofi's "Miracle Lab" styled booth showcases its global well-known brand and leading scientific research technology for intestinal health products (Enterogermina). Sanofi Consumer Healthcare aims to meet the high-quality self-care needs of Chinese consumers with a diversified product portfolio.

Sanofi Consumer Health Care Exhibits Multiple Popular Products at CIIE

"The CIIE is a world-class platform for high-level opening-up, bringing together top companies and their innovative products and technologies from around the globe. Sanofi Consumer Healthcare not only achieves win-win cooperation with various parties, but more importantly, brings more high-quality innovative products to more patients in China at a faster pace."Chen Xi, General Manager of Sanofi Consumer Healthcare China, stated,"Under the major trend of health consumption, the health market is full of potential and imagination. As a global leader in the consumer health field, we are always committed to introducing more innovative Sanofi global consumer health products into China, providing consumers with diverse, high-quality, and innovative new health options, and contributing to the realization of 'Healthy China.'"2030'。"

Sanofi's brand Enterogermina roadshow at the CIIE, dedicated to safeguarding gut health for Chinese consumers

At this year's CIIE, Sanofi Consumer Healthcare showcased its globally leading dedicated probiotics brand — Enterogermina, and conducted a roadshow event. This product, which originated in Europe and has been refined over 70 years, has since its inception demonstrated outstanding differentiated advantages globally. With clinically validated efficacy, it serves a wide range of people, including infants and young children, and is popular in 70 countries worldwide, recommended by authoritative foreign guidelines and Asian expert consensus. In May this year, Enterogermina officially launched three professional-grade probiotic products: the [Little Blue Box] for intestinal disorders, the [Little Pink Waist] focusing on weight management, and the [Little Gold Strip] targeting constipation and immunity. From development, production to promotion, all processes adhere to pharmaceutical standards, strictly selecting strains with interventional randomized double-blind controlled clinical trial levels. Each product contains hundreds of reports verifying its benefits for various intestinal health needs. With a professional and scientific attitude, Enterogermina, in collaboration with Dingxiang Doctor, pioneered the "Golden Five Forces" formula standard, providing customized solutions for the intestinal health of different populations, building intestinal health and resilience for the Chinese people.

热烈 audience interaction at the Meijunna roadshow

At the same time, Mejina also launched its globally popular liquid probiotic product for infants and young children on Tmall and JD cross-border e-commerce platforms this year.2Bvial), containing the original strain of Sanofi Group's Beauty & Health brand——Clostridium botulinum, which can effectively address diarrhea in infants and young children caused by antibiotics, as well as various other acute and chronic diarrheal conditions. It is currently the only probiotic strain that can be formulated into a liquid dosage form while still maintaining its activity and efficacy, solving a major challenge for many mothers on their journey of healthy parenting.

Penetrate multi-category layout, becoming the realization of "Healthy China"2030"A Reliable Partner

In addition, Sanofi Consumer Healthcare is committed to introducing and developing more high-quality products suitable for Chinese consumers, and continuously promoting the innovation and iteration of health supplements to meet the ever-evolving self-care needs of Chinese consumers.

Essentiale, a century-old professional liver care brand originating from Germany, has become a leader in China's OTC liver care product market since entering the Chinese market 30 years ago. Essentiale has deeply cultivated hospital, retail, and e-commerce channels, currently covering 11,000 hospitals and 130 fatty liver centers across China, helping approximately 4.2 million fatty liver patients improve their liver health. As an original non-prescription drug focusing on liver cell membrane repair, Essentiale’s exclusive core ingredient, polyenylphosphatidylcholine, is highly recommended by 30 expert consensuses and clinical guidelines in China. To further expand its liver care product line, Sanofi launched the sister brand of Essentiale, Essentiale Revital, in 2022. The two products under this brand, capsules and soft gummies, both use choline—an essential nutrient for the human body certified by the European Food Safety Authority—as the core formula, focusing on daily maintenance of liver cell membranes.

Its anti-allergy brand "Allegra" has also officially entered the Chinese market. Since its launch in the United States 25 years ago, "Allegra" has become the OTC brand most recommended by allergy prevention and treatment experts in the U.S. and has been highly praised by millions of American parents. One of its products, the Allegra Children's Berry-Flavored Suspension specifically developed for children aged 2-12, effectively relieves various allergy symptoms caused by allergens, such as runny nose, sneezing, itchy eyes, tearing, and itchy nose or throat. Moreover, the unique advantage of its superior formula is that it does not cross the blood-brain barrier, thus causing no drowsiness, which ensures children’s learning efficiency and focus. The berry flavor, which is very popular among children, greatly improves medication compliance. Chinese parents with allergy-prone children will be able to purchase this product on cross-border e-commerce platforms as soon as 2024.

The Healthy China 2030 strategy has now entered a critical phase. As consumers' attention to and awareness of daily health management continue to improve comprehensively, healthcare is gradually integrating into everyday life scenarios. Promoting the "greater health" of all citizens is a social responsibility that Sanofi Consumer Healthcare, as a localized multinational enterprise, needs to fulfill. We are committed to bringing our rich global assets to China, working with industry partners, combining local insights, continuously advancing technology, refining products, enhancing public health awareness, jointly promoting the standardization and professional development of the industry, facilitating the high-quality construction of China's consumer health market, and contributing to the realization of "Healthy China."